Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELPHI trial of paroxetine dose escalation in major depressive disorder
NL-OMON22147Active, not recruiting
- Sponsor
- n/a
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Paroxetine dose escalation with Placebo increase control (2 arms). Primary endpoints: Response rate, Remission rate and 2 more. Started Nov 2003; status: active, not recruiting.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON22147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22147.